Skip to main content
Clinical Trials/IRCT20230715058780N1
IRCT20230715058780N1RecruitingPhase 3

Comparative study of efficacy and side effects of combination Nesdonal - Fentanyl - Midazolam with Etomidate - Fentanyl - Midazolam for sedation of patients undergoing cataract surgery

Esfahan University of Medical Sciences0 sites52 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 3
Status
Recruiting
Enrollment
52

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 years to 70 years (—)
Sex
All

Inclusion Criteria

  • Cataract surgery candidates for emulsification method
  • Having (ASA) between 1 and 3
  • Age between 18 and 70 years
  • Consent to participate in the study

Exclusion Criteria

  • Parkinson's
  • Occurrence of acute cardiac ischemia in the last three months
  • Having a history of narcotic drugs use
  • Having a history of allergy to anesthetics
  • Weighing more than one hundred kilograms
  • Baseline blood pressure greater than 180/110

Investigators

Similar Trials

Comparative study of efficacy and side... | Clinical Trial